Publication

A phase i dose-escalation study of msc1992371a, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies

Graux, Carlos
Sonet, Anne
Maertens, Johan
Duyster, Justus
Greiner, Jochen
Chalandon, Yves
Martinelli, Giovanni
Hess, Dagmar
Heim, Dominik
Giles, Francis J.
... show 6 more
Citation
Graux, Carlos; Sonet, Anne; Maertens, Johan; Duyster, Justus; Greiner, Jochen; Chalandon, Yves; Martinelli, Giovanni; Hess, Dagmar; Heim, Dominik; Giles, Francis J. Kelly, Kevin R.; Gianella-Borradori, Athos; Longerey, Blandine; Asatiani, Ekaterine; Rejeb, Narmyn; Ottmann, Oliver G. (2013). A phase i dose-escalation study of msc1992371a, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies. Leukemia Research 37 (9), 1100-1106
Abstract
Funder
Publisher
Elsevier BV
Publisher DOI
10.1016/j.leukres.2013.04.025
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland